Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mona Khalaj

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Cell Biology|June 30, 2017
snoRNAs contribute to myeloid leukaemogenesisMona Khalaj, Christopher Y Park
Cell Stem Cell|July 5, 2014
Notch one up to stroma: endothelial notch prevents inflammation and myeloproliferationMona Khalaj, Christopher Y Park
Frontiers in Genetics|December 6, 2014
Pathogenic microRNA's in myeloid malignanciesMona Khalaj, Montreh Tavakkoli, Alec W Stranahan, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
High-Throughput Screening on Primary Tumor-Associated Microglia and Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy in GlioblastomaMona Khalaj, Madison L Gutierrez, Parisa Nejad, et al.
Leukemia|April 24, 2022
Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemiaAlec W Stranahan, Iryna Berezniuk, Sohini Chakraborty, et al.
Cell Journal|June 19, 2019
Gene Expression Patterns of Royan Human Embryonic Stem Cells Correlate with Their Propensity and Culture SystemsHassan Rassouli, Mona Khalaj, Seyedeh-Nafiseh Hassani, et al.
The Journal of Experimental Medicine|July 23, 2017
miR-99 regulates normal and malignant hematopoietic stem cell self-renewalMona Khalaj, Carolien M Woolthuis, Wenhuo Hu, et al.
Cancer Immunology Research|July 14, 2026
A Patient-Derived Screen Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Immunotherapy PartnersMona Khalaj, Andrew T Burden, Madison L Gutierrez, et al.
Journal of Psychiatric Research|May 29, 2018
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trialMona Khalaj, Amene Saghazadeh, Elham Shirazi, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Cell Biology|June 30, 2017
snoRNAs contribute to myeloid leukaemogenesisMona Khalaj, Christopher Y Park
Cell Stem Cell|July 5, 2014
Notch one up to stroma: endothelial notch prevents inflammation and myeloproliferationMona Khalaj, Christopher Y Park
Frontiers in Genetics|December 6, 2014
Pathogenic microRNA's in myeloid malignanciesMona Khalaj, Montreh Tavakkoli, Alec W Stranahan, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
High-Throughput Screening on Primary Tumor-Associated Microglia and Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy in GlioblastomaMona Khalaj, Madison L Gutierrez, Parisa Nejad, et al.
Leukemia|April 24, 2022
Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemiaAlec W Stranahan, Iryna Berezniuk, Sohini Chakraborty, et al.
Cell Journal|June 19, 2019
Gene Expression Patterns of Royan Human Embryonic Stem Cells Correlate with Their Propensity and Culture SystemsHassan Rassouli, Mona Khalaj, Seyedeh-Nafiseh Hassani, et al.
The Journal of Experimental Medicine|July 23, 2017
miR-99 regulates normal and malignant hematopoietic stem cell self-renewalMona Khalaj, Carolien M Woolthuis, Wenhuo Hu, et al.
Cancer Immunology Research|July 14, 2026
A Patient-Derived Screen Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Immunotherapy PartnersMona Khalaj, Andrew T Burden, Madison L Gutierrez, et al.
Journal of Psychiatric Research|May 29, 2018
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trialMona Khalaj, Amene Saghazadeh, Elham Shirazi, et al.
Science Translational Medicine|January 27, 2017
CD99 is a therapeutic target on disease stem cells in myeloid malignanciesStephen S Chung, William S Eng, Wenhuo Hu, et al.
Pageof 2